Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Commission urges low‑threshold wound care, self‑care kits and expanded harm reduction to address xylazine harms

Xylazine Commission (joint committee on mental health, substance use, and recovery) · December 11, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The commission's outreach and treatment subgroup recommended prioritizing wound care (including inexpensive self‑care kits), maintaining naloxone availability for polysubstance overdoses, expanding mobile/low‑threshold services, and mapping geographic treatment gaps to target investments.

Commission presenters framed xylazine-related harms as primarily clinical and service-access problems that can be mitigated by low-threshold interventions. Dr. Simeon Kimmel described common patterns: many people who are exposed to xylazine do not know it is present in the drugs they use and frequently self-manage wounds until they become severe. He recommended co‑locating wound care with syringe-service and harm‑reduction programs and pairing wound care with medications for opioid use disorder when appropriate.

Dr. David McGarry…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans